Nomura Holdings’s Clovis Oncology, Inc. CLVS Stock Holding History

Nomura Holdings’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-160,000	Closed	-$654K	–	1407
2019 Q3	$654K	Buy	160,000 +151,000	+1,678%	+$1.22M	﹤0.01%	926
2019 Q2	$138K	Buy	+9,000	New	+$163K	﹤0.01%	1048
2019 Q1	–	Sell	-3,200	Closed	-$57K	–	1463
2018 Q4	$57K	Buy	+3,200	New	+$65.4K	﹤0.01%	1132
2017 Q4	–	Sell	-20,000	Closed	-$1.65M	–	1726
2017 Q3	$1.65M	Buy	+20,000	New	+$1.59M	﹤0.01%	906
2015 Q3	–	Sell	-26,100	Closed	-$2.21M	–	2041
2015 Q2	$2.21M	Buy	+26,100	New	+$2.23M	0.01%	773
2013 Q4	–	Sell	-10,524	Closed	-$639K	–	2416
2013 Q3	$639K	Buy	+10,524	New	+$746K	﹤0.01%	1276

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Nomura Holdings's CLVS Position: Q4 2019 in Review

Nomura Holdings sold out of Clovis Oncology, Inc. (CLVS) in Q4 2019, closing a stake of 160,000 shares — an estimated $654K sold.

Nomura Holdings first reported a position in CLVS in Q3 2013 and held it in 6 quarters. The position peaked at $2.21M in Q2 2015. 147 funds tracked by Wall St. Rank hold CLVS as of Q4 2019.

Nomura Holdings reported no remaining Clovis Oncology, Inc. position as of Q4 2019 after selling out during the quarter.
Nomura Holdings sold 160,000 Clovis Oncology, Inc. shares in Q4 2019, an estimated $654K.
Nomura Holdings first reported a position in Clovis Oncology, Inc. in Q3 2013 and held it in 6 quarters.
Nomura Holdings's Clovis Oncology, Inc. position peaked at $2.21M in Q2 2015.
147 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2019.

Based on Nomura Holdings's 13F filing for Q4 2019, filed 14 Feb 2020.